CDC logo, Safer Healthier People  CDC HomeCDC SearchCDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us






5 - Thia - 1 - azabicyclo (4.2.0) oct - 2 - ene - 2 - carboxylic acid, 3 - (hydroxymethyl) - 8 - oxo - 7 - (2 - (2 - thienyl) acetamido) - , acetate (ester)

RTECS #: XI0388000

CAS #: 153-61-7


UPDATE: July 1997 MW: 396.46 MF: C16H16N2O6S2


NOTE:

TABLE OF CONTENTS:
  1. SYNONYMS:
  2. MUTATION DATA:
  3. REPRODUCTIVE EFFECTS DATA:
  4. ACUTE TOXICITY DATA:
  5. OTHER MULTIPLE DOSE DATA:
  6. NIOSH DOCUMENTATION AND SURVEILLANCE:
  7. REFERENCES:

SYNONYMS:

  1. 7 - (2 - Thienylacetamido) cephalosporanic acid
  2. 7 - (Thiophene - 2 - acetamido) cephalosporanic acid
  3. Cefalotin
  1. Cephalothin
  2. Cephalotin


SKIN AND EYE IRRITATION DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


MUTATION DATA AND REFERENCES:

SYSTEM TEST ROUTE/
ORGANISM/
TISSUE
DOSE REFERENCE
phage inhibition capacity other microorganisms 25 µg/plate ZMMPAO 231,369,1975


REPRODUCTIVE EFFECTS DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
subcutaneous
mouse
lowest published toxic dose: 18 gm/kg (9-11 day pregnant) Reproductive: Effects on embryo or fetus: Fetal death

Reproductive: Specific developmental abnormalities: Skin and skin appendages
SEIJBO 16,250,1976
subcutaneous
rat
lowest published toxic dose: 8,800 mg/kg (7-17 day pregnant) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)

Reproductive: Specific developmental abnormalities: Musculoskeletal system
NKRZAZ 27(Suppl 6),245,1979
unreported route
mouse
lowest published toxic dose: 9 gm/kg (9-11 day pregnant) Reproductive: Effects on embryo or fetus: Fetal death

Reproductive: Other developmental abnormalities
TJADAB 14,250,1976


TUMORIGENIC DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


ACUTE TOXICITY DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
intracerebral
mouse
lethal dose (50 percent kill): 81 mg/kg N/R AACHAX -,863,1965
intramuscular
mouse
lethal dose (50 percent kill): 7 gm/kg Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis) BYYADW 3,220,1978
intraperitoneal
rat
lethal dose (50 percent kill): 4,296 mg/kg N/R ANTBAL 26,44,1981
intravenous
mouse
lethal dose (50 percent kill): 4,990 mg/kg N/R NKRZAZ 26(Suppl 1),150,1978
intravenous
rat
lethal dose (50 percent kill): >5 gm/kg Behavioral: Convulsions or effect on seizure threshold

Lung, Thorax, or Respiration: Acute pulmonary edema

Kidney, Ureter, and Bladder: Other changes
NKRZAZ 31(Suppl 3),817,1983
parenteral
rat
lethal dose (50 percent kill): 23 mg/kg N/R AACHAX -,863,1965
subcutaneous
mouse
lethal dose (50 percent kill): >4 gm/kg N/R AMACCQ 3,40,1973
subcutaneous
rat
lethal dose (50 percent kill): 10 gm/kg Kidney, Ureter, and Bladder: Other changes NKRZAZ 27(Suppl 6),124,1979


OTHER MULTIPLE DOSE DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
intramuscular
rat
lowest published toxic dose: 31 gm/kg/31 day- intermittent Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis)

Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
ANTBAL 26,44,1981
intravenous
rat
lowest published toxic dose: 21 gm/kg/21 day- intermittent Kidney, Ureter, and Bladder: Changes in tubules (including acute renal failure, acute tubular necrosis)

Kidney, Ureter, and Bladder: Other changes in urine composition

Nutritional and Gross Metabolic: Changes in: Na
NKRZAZ 40(Suppl 4),162,1992
subcutaneous
rat
lowest published toxic dose: 70 gm/kg/35 day- intermittent Blood: Normocytic anemia

Skin: After systemic exposure: Dermatitis, other

Nutritional and Gross Metabolic: Weight loss or decreased weight gain
NKRZAZ 31(Suppl 3),817,1983


REVIEWS:

ORGANIZATION STANDARD
REFERENCE

N/R N/R N/R


STANDARDS AND REGULATIONS:

ORGANIZATION STANDARD
REFERENCE

N/R N/R N/R


NIOSH DOCUMENTATION AND SURVEILLANCE:

ORGANIZATION STANDARD or SURVEY
REFERENCE

National Occupational Hazard Survey 1974 National Occupational Hazard Survey 1974: Hazard Code: 83991;
Number of Industries 1;
Total Number of Facilities 33;
Number of Occupations 3;
Total Number of Employees Exposed 1,452
National Occupational Exposure Survey 1983 National Occupational Exposure Survey 1983: Hazard Code: 83991;
Number of Industries 1;
Total Number of Facilities 290;
Number of Occupations 8;
Total Number of Employees Exposed 21,013;
Total Number of Female Employees Exposed 19,052


STATUS IN FEDERAL AGENCIES:

ORGANIZATION
REFERENCE

N/R


REFERENCES:

CODEN
REFERENCE

AACHAX Antimicrobial Agents and Chemotherapy (1961-70). (Ann Arbor, MI) 1961-70. For publisher information, see AMACCQ.
AMACCQ Antimicrobial Agents and Chemotherapy. (American Soc. for Microbiology, 1913 I St., NW, Washington, DC 20006) V.1- 1972-
ANTBAL Antibiotiki. (Moscow, USSR) V.1-29, 1956-84. For publisher information, see AMBIEH.
BYYADW Byoin Yakugaku. Hospital Pharmacology. (Yakuji Nippon Sha, 1-11 Izumi-cho, Kanda, Chiyoda-ku, Tokyo 101, Japan) V.1- 1975-
NKRZAZ Chemotherapy (Tokyo). (Nippon Kagaku Ryoho Gakkai, 2-20-8 Kamiosaki, Shinagawa-Ku, Tokyo 141, Japan) V.1- 1953-
SEIJBO Senten Ijo. Congenital Anomalies. (Nippon Senten Ijo Gakkai, c/o Kinki Daigaku Igakubu Kaibagaku Kyoshitsu, 380 Nishiyama, Sayama-cho, Mirami-Kawachi-gun, Osaka-fu, Japan) V.1-26, 1960-86. For publisher information, see CGANE7.
TJADAB Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY 10003) V.1- 1968-
ZMMPAO Zentralblatt fuer Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene, Abteilung 1: Originale, Reihe A: Medizinische Mikrobiologie und Parasitologie. (Stuttgart, Fed. Rep. Ger.) V.217-245, 1971-79.

RTECS Compound Description:
   Drug
   Mutagen
   Reproductive Effector

Click Here for Additional Information about RTECS

NIOSH Home |  NIOSH Search  |  Site Index  |  Topic List |  Contact Us